Ирландия - английский - HPRA (Health Products Regulatory Authority)

bristol-myers squibb pharmaceuticals uc - aztreonam - powder for solution for injection/infusion - 1 gram(s) - monobactams; aztreonam

Ирландия - английский - HPRA (Health Products Regulatory Authority)

bristol-myers squibb pharmaceuticals uc - aztreonam - powder for solution for injection/infusion - 2 gram(s) - monobactams; aztreonam

Европейский союз - английский - EMA (European Medicines Agency)

gilead sciences ireland uc - aztreonam lysine - cystic fibrosis; respiratory tract infections - antibacterials for systemic use, - cayston is indicated for the suppressive therapy of chronic pulmonary infections due to pseudomonas aeruginosa in patients with cystic fibrosis (cf) aged 6 years and older.consideration should be given to official guidance on the appropriate use of antibacterial agents.

Канада - английский - Health Canada

gilead sciences canada inc - aztreonam - powder for solution - 75mg - aztreonam 75mg - monobactams

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

bristol-myers squibb pharmaceuticals ltd - aztreonam - powder for solution for injection - 1gram

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

bristol-myers squibb pharmaceuticals ltd - aztreonam - powder for solution for injection - 2gram

Израиль - английский - Ministry of Health

gilead sciences israel ltd - aztreonam - lyophilized powder for nebuliser solution - aztreonam 75 mg/vial - aztreonam - cayston is indicated for the suppressive therapy of chronic pulmonary infections due to pseudomonas aeruginosa in patients with cystic fibrosis (cf) aged 6 years and older. consideration should be given to official guidance on the appropriate use of antibacterial agents.

Израиль - английский - Ministry of Health

gilead sciences israel ltd - aztreonam - lyophilized powder for nebuliser solution - aztreonam 75 mg/vial - aztreonam - cayston is indicated for the suppressive therapy of chronic pulmonary infections due to pseudomonas aeruginosa in patients with cystic fibrosis (cf) aged 6 years and older. consideration should be given to official guidance on the appropriate use of antibacterial agents.

Сингапур - английский - HSA (Health Sciences Authority)

bristol-myers squibb (singapore) pte. ltd. - aztreonam - injection, powder, for solution - 1 g/vial - aztreonam 1 g/vial

Мальта - английский - Medicines Authority

p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - aztreonam - powder for solution for infusion or injection - aztreonam 1 g - antibacterials for systemic use